Zheng-Lin, B., Jaeger, E. B., Eslinger, C., Fragkogianni, M., Jariwala, U., Ashok, A., Layng, K. V., Shibuki, T., Abidoye, O., Hoyek, C., Pirozzi, A., Ahn, D. H., Jones, J. C., Wu, C., Borad, M. J., Sonbol, M. B., Strickler, J. H., Yoshino, T., Ikeda, M., Bekaii-Saab, T. S. (2026). Use of transcriptomic signatures of
                    <i>RAD51</i>
                    and
                    <i>GATA6</i>
                    to predict real-world overall survival with platinum therapy in
                    <i>BRCA/PALB2</i>
                    wild-type metastatic pancreatic cancer.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.2_suppl.679